Biomarkers in Aortic Stenosis - B.A.S.S.

CompletedOBSERVATIONAL
Enrollment

378

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Aortic StenosisDisorder of Prosthetic Cardiac ValveAortic Valve InsufficiencyMitral Valve InsufficiencyHypertrophic CardiomyopathyTricuspid Valve Insufficiency
Interventions
PROCEDURE

Blood Draw

"Two tubes of blood (about five tablespoons) will be drawn for research purposes, and these will be analyzed for the following tests:~1. BNP (Brain Natriuretic Peptide)~2. (PFA) Platelet Function Analyzer 100~3. von Willebrand Factor (vWF) antigen~4. (vWF) multimers~5. (vWF) \*activity by latex aggregation~6. Plasma stored for development of new testing approaches"

Trial Locations (1)

32224

Mayo Clinic, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT01334801 - Biomarkers in Aortic Stenosis - B.A.S.S. | Biotech Hunter | Biotech Hunter